Tilray’s U.S.-listed stock rallied nearly 9% after better-than-expected quarterly sales and a 2025 revenue outlook that’s ahead of estimates.
Bringing you TOP Pot Stocks!
Tilray’s U.S.-listed stock rallied nearly 9% after better-than-expected quarterly sales and a 2025 revenue outlook that’s ahead of estimates.
Copyright © 2025 Cannabis Stocks News
Recent Comments